Thaddeus Riley
Family Medicine · Statesboro, GANPI 1104874031
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,694 of the $6,806 with a category attached, or 83.7%. It is spread thinly across 52 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,680 and has fallen 98.3% since, to $46 in 2025. Among family medicine clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 310 payments — averaging $21.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$1K
- AbbVie$830
- Amgen$685
- AstraZeneca$562
- Boehringer Ingelheim$296
- Bayer$268
- plus $3K from 46 others
Across 417 payments — averaging $1195.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$491K
- Sanofi US Services Inc.$8K
What the payments were for
- Travel & lodging$1,08216%
- Food & beverage$5,69484%
- Education$300%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,806 in reported general payments places this provider in the 90th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 27 | $11,983 |
| Atorvastatin Calcium | 36 | $342 |
| Gabapentin | 18 | $308 |
| Escitalopram Oxalate | 13 | $243 |
| Pantoprazole Sodium | 16 | $232 |
| Alendronate Sodium | 13 | $201 |
| Metformin Hcl ErMetformin Hcl | 19 | $189 |
| Rosuvastatin Calcium | 17 | $157 |
| Losartan Potassium | 17 | $152 |
| Amlodipine Besylate | 20 | $127 |
| Omeprazole | 14 | $103 |
| Tamsulosin Hcl | 11 | $75 |
| Metoprolol Tartrate | 11 | $15 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $226 | $11,98327 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Statesboro
- Jeffrey KingsleyColumbus$404K
- Debbie HaginsSavannah$279K
- Yolanda WadeTyrone$233K
- Julian HutchinsWarrenton$222K
- Nadine Halliburton-FosterCumming$219K
- Contessa MetcalfeAtlanta$157K
- Elmore AlexanderStone Mountain$155K
- Bantwal BaligaColumbus$115K
- Avril CampbellFort Benning$108K
- Mitzi RubinMarietta$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.